Doctor profile · Federal record
Dr. BETHANY ROHR, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · Dermatology Physician · Student in an Organized Health Care Education/Training Program · CLEVELAND, OH
- NPI 1316365356
- Accepts Medicare
- 12 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
11100 EUCLID AVE
CLEVELAND, OH 441061716
(844) 842-0756 - Additional location
-
16 Woodbine Ln
Danville, PA 178218029
(570) 271-8050
fax (570) 271-5940
Credentials & registration
- NPI registered
- April 2014 — 12 yrs on file
- Profile last updated
- December 17, 2020
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Ohio #35.136882 · Pennsylvania #MD464986
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316365356. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,624
Distinct HCPCS
10
Medicare allowed
$174,884
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 1,389 | 872 | $67 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 242 | 57 | $6 | |
88341 |
Special stained specimen slides to examine tissue, each additional procedure | 219 | 52 | $80 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 155 | 116 | $86 | |
88342 |
Special stained specimen slides to examine tissue, initial procedure | 130 | 103 | $92 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 94 | 70 | $122 | |
17000 |
Destruction of precancer skin growth, 1 growth | 91 | 76 | $54 | |
96900 |
Application of ultraviolet light to skin | 90 | 12 | $22 | |
88312 |
Special stained specimen slides to identify organisms including interpretation and report | 69 | 41 | $97 | |
11102 |
Biopsy of related skin growth, first growth | 40 | 37 | $94 |
In context: peer comparison
Among 26 peers in this city , average services per provider: 95. This provider delivers 28× the peer median.Open Payments
Industry payments received
All-time total
$61
Transactions
3
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $27.49 | |
| Arcutis Biotherapeutics, Inc. | 1 | $17.65 | |
| ABBVIE INC. | 1 | $15.62 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
361
Patients
93
Total drug cost
$62,694
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 57 | 20 | $1,979 |
| Triamcinolone Acetonide | Generic | 52 | 30 | $356 |
| Metronidazole | Generic | 41 | 12 | $3,343 |
| Clobetasol Propionate | Generic | 34 | 20 | $2,292 |
| Doxycycline Hyclate | Generic | 28 | 0 | $1,151 |
| Tacrolimus | Generic | 20 | 11 | $4,001 |
| Prednisone | Generic | 19 | 0 | $32 |
| Hydrocortisone | Generic | 18 | 0 | $144 |
| Gabapentin | Generic | 16 | 0 | $111 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 15 | 0 | $727 |